Compliance with saliva sampling protocols: Electronic monitoring reveals invalid cortisol daytime profiles in noncompliant subjects

Psychosomatic Medicine

Volumn 65, Issue 2, 2003, Pages 313-319

  Kudielka, Brigitte M ^a   Broderick, Joan E ^b   Kirschbaum, Clemens ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

Awakening cortisol response; Circadian rhythm; Compliance; Electronic monitoring; Salivary cortisol; Sampling accuracy

Indexed keywords

HYDROCORTISONE;

ACCURACY; ADOLESCENT; ADULT; AGED; AMBULATORY CARE; ARTICLE; CIRCADIAN RHYTHM; CLINICAL PROTOCOL; DEVICE; ELECTRONICS; FEMALE; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; INFORMED CONSENT; MALE; MEASUREMENT; NORMAL HUMAN; PATIENT COMPLIANCE; PATIENT MONITORING; PRIORITY JOURNAL; QUESTIONNAIRE; SALIVA; SAMPLING; SELF REPORT; STATISTICAL SIGNIFICANCE; TECHNIQUE; TIME; TREATMENT INDICATION; WAKEFULNESS;

ADOLESCENT; ADULT; AGED; CIRCADIAN RHYTHM; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; MONITORING, AMBULATORY; PATIENT COMPLIANCE; SALIVA;

EID: 0037345021     PISSN: 00333174     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PSY.0000058374.50240.BF     Document Type: Article

References (54)

1. Rudd P, Ahmed S, Zachary V, Barton C, Bonduelle D. Improved compliance measures: applications in an ambulatory hypertensive drug trial. Clin Pharmacol Ther 1990;48:676-85.
2. Elixhauser A, Eisen SA, Romeis JC, Homan SM. The effect of monitoring and feedback on compliance. Med Care 1990;28: 882-93.
3. Tashkin DP, Rand C, Nides M, Simmons M, Wise R, Coulson AH, Li V, Gong H. A nebulizer chronolog to monitor compliance with inhaler use. Am J Med 1991;91:S33-6.
4. Spector SL, Kinsman R, Mawhinney H, Siegel SC, Rachelefsky GS, Katz RM, Rohr AS. Compliance of patients with asthma with an experimental aerosolized medication: implications for controlled clinical trials. J Allergy Clin Immunol 1986;77:65-70.
5. Gong H, Simmons MS, Clark VA, Tashkin DP. Metered-dose inhaler usage in subjects with asthma: comparison of nebulizer chronolog and daily diary. J Allergy Clin Immunol 1988;82: 5-10.
6. Milgrom H, Bender B, Ackerson L, Bowry P, Smith B, Rand C. Noncompliance and treatment failure in children with asthma. J Allergy Clin Immunol 1996;98:1051-7.
7. Berg J, Dunbar-Jacob J, Rohay JM. Compliance with inhaled medications: the relationship between diary and electronic monitor. Ann Behav Med 1998;20:36-8.
8. Melbourne KM, Geletko SM, Brown SL, Willey-Lessne C, Chase S, Fisher A. Medication adherence in patients with HIV infection: a comparison of two measurement methods. AIDS Reader 1999;9:329-38.
9. Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Ouellette VL. How often is medication taken as prescribed? A novel assessment technique. JAMA 1989;261:3273-7.
10. Glover F. Dispenser for pharmaceutics having patients compliance monitor apparatus. US patent 4 034 757. July 12, 1977.
11. Kass MA, Meltzer DW, Gordon M. A miniature compliance monitor for eyedrop medication. Arch Ophthalmol 1984;102: 1550-4.
12. Eisen SA, Woodward RS, Miller D, Spitznagel E, Windham CA. The effect of medication compliance on the control of hypertension. J Gen Intern Med 1987;2:298-305.
13. Urquahrt J, de Klerk E. Contending paradigms for the interpretation of data on patient compliance with therapeutic drug regimens. Stat Med 1998;17:251-67.
14. Urquahrt J. The electronic medication event monitor: lessons for pharmacotherapy. Clin Pharmacokinet 1997;32:345-56.
15. Maenpaa H, Javela K, Pikkarainen J, Malkonen M, Heinonen OP, Manninen V. Minimal doses of digoxin: a new marker for compliance to medication. Eur Heart J 1987;8(Suppl I):31-7.
16. Maenpaa H, Manninen V, Heinonen OP. Comparison of the digoxin marker with capsule counting and compliance questionnaire methods for measuring compliance to medication in a clinical trial. Eur Heart J 1987;8(Suppl I):39-43.
17. Feely M, Cooke J, Price D, Singleton S, Mehta A, Bradford L, Calvert R. Low-dose phenobarbitone as an indicator of compliance with drug therapy. Br J Clin Pharmacol 1987;24:77-83.
18. Cramer JA. Microelectronic systems for monitoring and enhancing patient compliance with medication regimens. Drugs 1995; 49:321-7.
19. Cramer JA, Ouelette VL, Mattson RH. The effect of microelectronic observation on compliance. Epilepsia 1990;31:617-8.
20. Nides MA, Tashin DP, Simmons MS, Wise RA, Li VC, Rand CS. Improving inhaler adherence in a clinical trial through the use of the nebulizer chronolog. Chest 1993;104:501-7.
21. Rand CS, Wise RA, Nides M, Simmons MS, Bleecker ER, Kusek JW, Li VC, Tashkin DP. Metered-dose inhaler adherence in a clinical trial. Am Rev Respir Dis 1992;146:1559-64.
22. Kruse W, Weber E. Dynamics of drug regimen compliance - its assessment by microprocessor-based monitoring. Eur J Clin Pharmacol 1990;38:561-5.
23. Norman G, McFarlane A, Streiner D, Neale K. Health diaries: strategies for compliance and relation to other measures. Med Care 1982;20:623-9.
24. Sherliker L, Steptoe A. Coping with new treatments for cancer: a feasibility study of daily diary measures. Patient Educ Counsel 2000;40:11-9.
25. De Wit R, van Dam F, Hanneman M, Zandbelt L, van Buuren A, van der Heijden K, Leenhouts G, Loonstra S, Huijer Abu-Saad H. Evaluation of the use of a pain diary in chronic cancer pain patients at home. Pain 1999;79:89-99.
26. Stone A, Shiffman S, Schwartz J, Broderick J, Hufford M. Patient compliance with paper diaries. BMJ 2002;324:1193-4.
27. McKenney JM, Munroe WP, Wright JT. Impact of an electronic medication compliance aid on long-term blood pressure control. J Clin Pharmacol 1992;32:277-83.
28. Urquahrt J. Patient compliance with drug regimens: measurement, clinical correlates, economic impact. Eur Heart J 1997; 17(Suppl A):8-15.
29. Urquhart J. Ascertaining how much compliance is enough with outpatient antibiotic regimens. Postgrad Med J 1992;68(Suppl 3):49-59.
30. Mallion JM, Meilhac B, Tremel F, Calvez R, Bertholom N. Use of microprocessor-equipped tablet box in monitoring compliance with antihypertensive treatment. J Cardiovasc Pharmacol 1992; 19(Suppl 2):S41-8.
31. Mallion JM, Baguet JP, Siche JP, Tremel F, de Gaudemaris R. Compliance, electronic monitoring and antihypertensive drugs. J Hypertens 1998;16(Suppl 1):S75-80.
32. Shiffman S. Real-time self-report of momentary states in the natural environment: computerized ecological momentary assessment. In: Stone A, Turkkan JS, Bachrach C, Jobe J, Kurtzman H, Cain V, editors. The science of self-report: implications for research and practice. Mahwah (NJ): Lawrence Erlbaum Associates; 2000. p. 277-96.
33. Hyland M, Kenyon C, Allen R, Howard P. Diary keeping in asthma: comparison of written and electronic methods. BMJ 1993;306:487-9.
34. Kirschbaum C, Hellhammer DH. Salivary cortisol in psychoneuroendocrine research: recent developments and applications. Psychoneuroendocrinology 1994;19:313-33.
35. Kirschbaum C, Hellhammer DH. Salivary cortisol. In: Fink G, editor. Encyclopedia of stress. Vol 3. San Diego (CA): Academic Press; 2000. p. 379-83.
36. Flinn MV, England BG. Social economics of childhood glucocorticoid stress response and health. Am J Phys Anthropol 1997;102:33-53.
37. Dressendörfer RA, Kirschbaum C, Rohde W, Stahl F, Strasburger CJ. Synthesis of a cortisol-biotin conjugate and evaluation as a tracer in an immunoassay for salivary cortisol measurement. J Steroid Biochem Mol Biol 1992;43:683-92.
38. Pruessner JC, Wolf OT, Hellhammer DH, Buske-Kirschbaum A, von Auer K, Jobst S, Kaspers F, Kirschbaum C. Free cortisol levels after awakening: a reliable biological marker for the assessment of adrenocortical activity. Life Sci 1997;61:2539-49.
39. Greenhouse SW, Geisser S. On methods in the analysis for profile data. Psychometrica 1959;24:95-112.
40. Vasey MW, Thayer JF. The continuing problem of false positives in repeated measures ANOVA in psychophysiology: a multivariate solution. Psychophysiology 1987;24:479-86.
41. Brown LL, Tomarken AJ, Orth DN, Loosen PT, Kalin NH, Davidson RJ. Individual differences in repressive-defensiveness predict basal salivary cortisol levels. J Pers Soc Psychol 1996; 70:362-71.
42. van Eck M, Berkhof H, Nicolson N, Sulon J. The effects of perceived stress, traits, mood states, and stressful daily events on salivary cortisol. Psychosom Med 1996;58:447-58.
43. Bertagna X, Escourolle H, Pinquier JL, Coste J, Raux-Demay MC, Perles P, Silvestre L, Luton JP, Strauch G. Administration of RU 486 for 8 days in normal volunteers: antiglucocorticoid effect with no evidence of peripheral cortisol deprivation. J Clin Endocrinol Metab 1994;78:375-80.
44. Smyth J, Ockenfels MC, Porter L, Kirschbaum C, Hellhammer DH, Stone AA. Stressors and mood measured on a momentary basis are associated with salivary cortisol. Psychoneuroendocrinology 1998;23:353-73.
45. Scheer FA, Buijs RM. Light affects morning salivary cortisol in humans. J Clin Endocrinol Metab 1999;84:3395-8.
46. Adam EK, Gunnar MR. Relationship functioning and home and work demands predict individual differences in diurnal cortisol patterns in women. Psychoneuroendocrinology 2001;26: 189-208.
47. Wüst S, Wolf J, Hellhammer DH, Federenko I, Schommer N, Kirschbaum C. The cortisol awakening response - normal values and confounds. Noise Health 2000;7:77-85.
48. Sephton S, Sapolsky R, Kraemer H, Spiegel D. Diurnal cortisol rhythm as a predictor of breast cancer survival. J Natl Cancer Inst 2000;92:994-1000.
49. Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet 1999;354:1435-9.
50. Stone AA, Schwartz JE, Smyth J, Kirschbaum C, Cohen S, Hellhammer D, Grossman S. Individual differences in the diurnal cycle of salivary free cortisol: a replication of flattened cycles for some individuals. Psychoneuroendocrinology 2001;26:295-306.
51. Smyth JM, Ockenfels MC, Gorin AA, Catley D, Porter LS, Kirschbaum C, Hellhammer DH, Stone AA. Individual differences in the diurnal cycle of cortisol. Psychoneuroendocrinology 1997;22:89-105.
52. Litt M, Cooney N, Morse P. Ecological Momentary Assessment (EMA) with treated alcoholics: methodological problems and potential solutions. Health Psychol 1998;17:48-52.
53. Yeung M, O'Connor S, Parry D, Cochrane G. Compliance with prescribed drug therapy in asthma. Respir Med 1994;88:31-5.
54. Csikszentmihalyi M, Larsen R. Validity and reliability of the experience-sampling method. J Nerv Ment Dis 1987;175: 526-36.